Vivoz Biolabs

United Kingdom
Newyork, Argyll and Bute, United Kingdom, 10027

Company profile

Vivoz Biolabs company profile

Vivoz Biolabs develops cell culture platforms that are designed to mimic the dynamic 3D tumor microenvironment. The company aims to commercialize its layered microfluidic tissue assay, a patented technology that can be used as an ex vivo platform for drug screening and diagnosis, and a device for personalized cancer treatment.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2010-01-01, Year

Headquarters

Postal code
10027
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $224,700 / 2019-12-02
Investors
1
Lead investors
1
Founders
2

Founders and investors

Founders

Sihong WangXuejun Jiang

Lead investors

National Science Foundation

Investors

National Science Foundation